205 search results
- Current search:
- Infectious Diseases
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 11 Jul 2017
Antiretroviral resistance testing in people living with HIV
Protocol: To evaluate the effectiveness of antiretroviral resistance testing (genotypic or phenotypic) in reducing mortality and morbidity in people living with HIV. -
NewCochrane EvidencePublished 10 Jul 2017
Ribavirin for treating Crimean Congo haemorrhagic fever
Protocol: To assess the effects of ribavirin for treating people with Crimean Congo Haemorrhagic Fever (CCHF). -
TitlePublished 2 Jul 2017
Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis
Infectious Diseases Group Mbah Okwen Title Monday, June 26, 2017 ... -
NewCochrane EvidencePublished 16 Jun 2017
Insecticide space spraying for preventing malaria transmission
Protocol: Primary objective To evaluate the impact of space spraying on malaria transmission and vector populations, or the incremental impact when applied in combination with other malaria control methods, in comparison to equivalent conditions with no space spraying intervention. Secondary objective To guide future evaluations of strategies ... -
NewCochrane EvidencePublished 12 Jun 2017
The combination of indoor residual spraying with insecticide-treated nets versus insecticide-treated nets alone for preventing malaria
Protocol: To evaluate whether indoor residual spraying (IRS) in combination with long-lasting insecticide-treated nets (LLINs)/insecticide-treated nets (ITNs) causes an additional reduction to malaria transmission versus LLINs/ITNs alone. -
Cochrane EvidencePublished 25 May 2017
Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults
Why did we do this review? HIV is still a major cause of death worldwide, particularly in Africa. HIV multiplies in the blood and damages the immune system. Therefore if HIV-positive, one is more vulnerable to contract infections. The current drug treatment, antiretroviral therapy (ART), stops the virus from multiplying thereby allowing the body's ... -
Cochrane EvidencePublished 25 May 2017
The accuracy of rapid diagnostic tests for detecting typhoid and paratyphoid (enteric) fever
Cochrane researchers assessed the accuracy of commercially-available rapid diagnostic tests and their prototypes (including TUBEX, Typhidot, Typhidot-M, Test-it Typhoid, and other tests) for detecting typhoid and paratyphoid (enteric) fever in people living in countries where the estimated number of individuals with the disease at any one time is greater ... -
TitlePublished 23 Jul 2017
Antifungal interventions for primary prevention of cryptococcal disease in adults and children with HIV
Infectious Diseases Group Ajibola Awotiwon Title Tuesday, May 16, 2017 ... -
Cochrane EvidencePublished 18 May 2017
Micronutrient supplements for non-pregnant adults with HIV infection
Cochrane researchers conducted a review of the effects of micronutrient supplements for people living with HIV. This is an update of a Cochrane Review previously published in 2010. After searching for relevant trials up to 18 November 2016, the review authors included 33 trials. Thirteen of these trials included people not on HIV treatment and were ... -
TitlePublished 7 May 2017
Contact tracing strategies in household and congregate environments to identify latent cases of tuberculosis in moderate and low incidence populations
Infectious Diseases Group Darryl Braganza Menezes Title Friday, May 5, 2017 ...